The MYDECINE brand, founded in 2018 (Canada), from 1 sister brand and 4958 competing brands. MYDECINE is owned by MYDECINE INNOVATIONS GROUP INC., listed on the stock exchange of Francfort Its International Securities Identification Number (ISIN) is CA62848R1064. MYDECINE is part of the Drug Manufacturers activity sector.